Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Angle Plc (AGLE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.00 +0.25    +2.13%
19/04 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 1,289,781
  • Bid/Ask: 11.50 / 13.50
  • Day's Range: 11.26 - 12.25
Type:  Equity
Market:  United Kingdom
ISIN:  GB0034330679 
SEDOL:  3433067
Angle 12.00 +0.25 +2.13%

Angle Company Profile

 
Read the Angle company profile to learn more about the business and the management team. View Angle Plc facts about employee data, company products and services, and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

-

Equity Type

ORD

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Contact Information

Address Surrey Research Park 10 Nugent Road
Guildford, GU2 7AF
United Kingdom
Phone 44 14 8334 3434
Fax -

Top Executives

Name Age Since Title
Andrew David William Newland 59 2004 Founder, CEO & Executive Director
Ian Francis Griffiths 56 2004 CFO, Finance Director, Company Secretary & Executive Director
Jan Groen 61 2018 Independent Non-Executive Director
Clive Stanway - - Member of Scientific Advisory Board
Ashok Venkitaraman - - Member of Scientific Advisory Board
James M. Reuben - 2015 Member of Scientific Advisory Board
Adrian Newland - - Member of Scientific Advisory Board
Brian Howlett 78 2013 Non-Executive & Senior Independent Director
Harold Swerdlow - - Member of Scientific Advisory Board
Greg L. Shaw - - Member of Scientific Advisory Board
Joseph D. Khoury - 2018 Member of Scientific Advisory Board
Juliet Thompson 57 2023 Non-Executive Director
Joseph E. Eid 55 2023 Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AGLE Price Commentary

Write your thoughts about Angle Plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Theo Marshall
Theo Marshall May 25, 2023 8:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Still buying after today's announcement.
Theo Marshall
Theo Marshall May 18, 2023 8:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Too cheap
virg smit
virg smit Jan 31, 2022 17:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1643649862_23581.jpg
Whilst there is no news the share price will drift off to the £1.00 region-its worth considering adding to holdings if the price sinks somewhat further towards the 80+region.
virg smit
virg smit Oct 15, 2021 11:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The prognosis for this share price is unbeleivable as the CEO is aiming to dominate the world with blood tests that find and deliver live cancer cells-so no more biopsies !The assumption is the USA FDA approve their M/C application which is expected towards the end of the year.Some ridiculous projections for the sp suggest circa £1500 yes thats one thousand five hundred pounds a share-because their is no competition -suggest check out the website for the full details of patients, posters and peer reviews.Of course the immediate share price will collapse and recover if no FDA approval-nevertheless a holding of a couple of thousand shares will give £3million in a very short time IF APPROVED.Many years of trading and I have never seen anything like this.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email